{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:28:51Z","timestamp":1769239731676,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/00513"],"award-info":[{"award-number":["PI13\/00513"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["P14\/00253"],"award-info":[{"award-number":["P14\/00253"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["19245\/PI\/14"],"award-info":[{"award-number":["19245\/PI\/14"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Murciano de Investigaci\u00f3n Biosanitaria","award":["IMIB16\/AP\/01\/06"],"award-info":[{"award-number":["IMIB16\/AP\/01\/06"]}]},{"name":"Sociedad Espa\u00f1ola de Trombosis y Hemostasia"},{"name":"Pfizer\/Bristol-Myers-Squibb"},{"name":"ISCIII\/FEDER","award":["RD12\/0042\/0068"],"award-info":[{"award-number":["RD12\/0042\/0068"]}]},{"name":"ISCIII\/FEDER","award":["RD12\/0042\/0010"],"award-info":[{"award-number":["RD12\/0042\/0010"]}]},{"name":"ISCIII\/FEDER","award":["RD12\/0042\/0069"],"award-info":[{"award-number":["RD12\/0042\/0069"]}]},{"name":"ISCIII\/FEDER","award":["RD12\/0042\/0063"],"award-info":[{"award-number":["RD12\/0042\/0063"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.amjcard.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T16:40:39Z","timestamp":1505839239000},"page":"2176-2181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0492-6241","authenticated-orcid":false,"given":"Jos\u00e9 Miguel","family":"Rivera-Caravaca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Asunci\u00f3n","family":"Esteve-Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Ra\u00f1a-M\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Cequier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Bertomeu-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Yoke Hong","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.09.003_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11739-015-1326-1","article-title":"Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score","volume":"11","author":"Pastori","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0020","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0030","series-title":"Statistical Methods in Diagnostic Medicine","author":"Zhou","year":"2002"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0050","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0055","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/STROKEAHA.110.589218","article-title":"Stroke risk and antithrombotic strategies in atrial fibrillation","volume":"41","author":"Medi","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0060","doi-asserted-by":"crossref","first-page":"16016","DOI":"10.1038\/nrdp.2016.16","article-title":"Atrial fibrillation","volume":"2","author":"Lip","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0065","first-page":"929","article-title":"Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalization","volume":"19","author":"Massera","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11739-010-0352-2","article-title":"The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue","volume":"5","author":"Polimeni","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0080","doi-asserted-by":"crossref","first-page":"e003347","DOI":"10.1161\/JAHA.116.003347","article-title":"Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms","volume":"5","author":"Violi","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0085","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/CIRCULATIONAHA.114.014145","article-title":"Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the atherosclerosis risk in communities (ARIC) study","volume":"131","author":"Soliman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14656566.2016.1267140","article-title":"Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation","volume":"18","author":"Mar\u00edn","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0095","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.amjmed.2016.06.045","article-title":"Causes of deaths and influencing factors in patients with atrial fibrillation","volume":"129","author":"Fauchier","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/europace\/euu008","article-title":"Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey","volume":"16","author":"Potpara","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0105","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjcard.2016.06.018","article-title":"Evaluation of 5 prognostic scores for prediction of stroke, thromboembolic and coronary events, all-cause mortality, and major adverse cardiac events in patients with atrial fibrillation and coronary stenting","volume":"118","author":"Fauchier","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1076029616646874","article-title":"CHA2DS2-VASc score predicts in-hospital and long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention","volume":"23","author":"Bozbay","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jjcc.2012.01.003","article-title":"Relationship between CHA2DS-VASc scores and ischemic stroke\/cardiovascular events in Japanese patients with paroxysmal atrial fibrillation without receiving anticoagulant therapy","volume":"59","author":"Komatsu","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0120","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.amjcard.2012.01.371","article-title":"CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation\/atrial flutter patients","volume":"109","author":"Naccarelli","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejim.2016.09.010","article-title":"CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome","volume":"36","author":"Rozenbaum","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjcard.2017.09.003_bib0130","first-page":"742","article-title":"CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events","volume":"16","author":"Tasolar","year":"2016","journal-title":"Anatol J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917314595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917314595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T10:51:07Z","timestamp":1535367067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917314595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0002914917314595"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.09.003","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}